Lemaitre Vascular 

$80.62
71
+$0.13+0.16% 15:52 Today

Statistics

Day High
80.8
Day Low
79.7
52W High
118.01
52W Low
78.27
Volume
1,177
Avg. Volume
-
Mkt Cap
1.84B
P/E Ratio
37.77
Dividend Yield
1.24%
Dividend
1

Upcoming

Dividends

1.24%Dividend Yield
Sep 26
$0.25
Jun 26
$0.25
Mar 26
$0.25
Dec 25
$0.20
Sep 25
$0.20
10Y Growth
18.43%
5Y Growth
17.45%
3Y Growth
20.35%
1Y Growth
25%

Earnings

22OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.48
0.59
0.7
0.81
Expected EPS
0.686125
Actual EPS
N/A

Financials

23.13%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
249.6MRevenue
57.73MNet Income

Analyst Ratings

113.67Average Price Target
The highest estimate is 127.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
33%
Hold
67%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LMAT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.77B
Medtronic is a major player in the medical devices sector, offering a wide range of products that compete directly with Lemaitre Vascular's vascular surgery and endovascular therapy products.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation specializes in the development of medical devices that are used in various interventional medical specialties, including those that overlap with Lemaitre Vascular's market.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories operates in multiple segments of healthcare, including vascular care, where its products compete with those offered by Lemaitre Vascular.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. provides a broad array of medical devices and products, including those for hemodialysis and endovascular therapies, making it a competitor in the vascular space.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the cardiovascular market space with products that can be alternatives to those of Lemaitre Vascular.
Integra Lifesciences
IART
Mkt Cap1.31B
Integra LifeSciences Holdings Corporation offers products in the areas of neurosurgery, regenerative medicine, and extremity reconstruction, including vascular solutions that compete with Lemaitre Vascular.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation is a global leader in medical technology, including surgical equipment and neurovascular products, that competes with Lemaitre Vascular in the medical devices market.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but has expanded into surgical products that can be used in vascular surgery, positioning it as a competitor.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical devices segment, offers a wide range of products, including those for cardiovascular care, competing with Lemaitre Vascular's offerings.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries Limited is primarily known for pharmaceuticals but has ventured into medical devices, including those for vascular health, indirectly competing with Lemaitre Vascular.

About

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Show more...
CEO
George W. LeMaitre
Employees
655
Country
United States
ISIN
US5255582018
WKN
000A0LB2B

Listings

0 Comments

Share your thoughts

FAQ

What is Lemaitre Vascular stock price today?
The current price of LMAT is $80.62 USD — it has increased by +0.16% in the past 24 hours. Watch Lemaitre Vascular stock price performance more closely on the chart.
What is Lemaitre Vascular stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Lemaitre Vascular stocks are traded under the ticker LMAT.
Is Lemaitre Vascular stock price growing?
LMAT stock has risen by +0.47% compared to the previous week, the month change is a -23.59% fall, over the last year Lemaitre Vascular has showed a -16.74% decrease.
What is Lemaitre Vascular market cap?
Today Lemaitre Vascular has the market capitalization of 1.84B
When is the next Lemaitre Vascular earnings date?
Lemaitre Vascular is going to release the next earnings report on October 22, 2026.
What were Lemaitre Vascular earnings last quarter?
LMAT earnings for the last quarter are 0.74 USD per share, whereas the estimation was 0.81 USD resulting in a -8.27% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lemaitre Vascular revenue for the last year?
Lemaitre Vascular revenue for the last year amounts to 249.6M USD.
What is Lemaitre Vascular net income for the last year?
LMAT net income for the last year is 57.73M USD.
Does Lemaitre Vascular pay dividends?
Yes, LMAT dividends are paid quarterly. The last dividend per share was 0.25 USD. As of today, Dividend Yield (FWD)% is 1.24%.
How many employees does Lemaitre Vascular have?
As of September 04, 2026, the company has 655 employees.
In which sector is Lemaitre Vascular located?
Lemaitre Vascular operates in the Health & Wellness sector.
When did Lemaitre Vascular complete a stock split?
Lemaitre Vascular has not had any recent stock splits.
Where is Lemaitre Vascular headquartered?
Lemaitre Vascular is headquartered in BURLINGTON, United States.